IRIS
SCHIRINZI, TOMMASO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.006
AS - Asia 3.483
EU - Europa 2.487
SA - Sud America 529
AF - Africa 61
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 21.579
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.865
SG - Singapore 1.625
IT - Italia 930
CN - Cina 556
BR - Brasile 425
RU - Federazione Russa 361
HK - Hong Kong 330
VN - Vietnam 279
IE - Irlanda 211
DE - Germania 187
KR - Corea 185
BD - Bangladesh 153
UA - Ucraina 133
GB - Regno Unito 129
FR - Francia 123
JP - Giappone 116
NL - Olanda 93
CA - Canada 79
FI - Finlandia 79
IN - India 66
SE - Svezia 61
PL - Polonia 47
AR - Argentina 44
MX - Messico 37
AT - Austria 34
ID - Indonesia 33
ZA - Sudafrica 29
IQ - Iraq 20
TR - Turchia 20
EC - Ecuador 18
ES - Italia 18
JO - Giordania 16
AL - Albania 10
CH - Svizzera 10
BE - Belgio 9
CO - Colombia 9
VE - Venezuela 9
KG - Kirghizistan 8
LT - Lituania 8
MA - Marocco 8
PK - Pakistan 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
PT - Portogallo 7
KE - Kenya 6
MY - Malesia 6
TH - Thailandia 6
AU - Australia 5
CL - Cile 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
EG - Egitto 5
HR - Croazia 5
IR - Iran 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 5
RS - Serbia 5
TN - Tunisia 5
UY - Uruguay 5
DK - Danimarca 4
EU - Europa 4
GR - Grecia 4
IL - Israele 4
NP - Nepal 4
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
HN - Honduras 3
JM - Giamaica 3
BG - Bulgaria 2
GE - Georgia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
DZ - Algeria 1
GA - Gabon 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
MZ - Mozambico 1
Totale 21.570
Salva come PNG Salva come JPEG
Città #
Wilmington 3.522
Houston 3.122
Woodbridge 2.641
Singapore 884
Fairfield 534
Ashburn 510
San Jose 430
Chandler 363
Hong Kong 327
Rome 270
Ann Arbor 231
Seattle 228
Beijing 196
Council Bluffs 189
Cambridge 187
Dublin 184
New York 176
Santa Clara 142
The Dalles 131
Medford 129
Dallas 123
Tokyo 113
Dearborn 110
Los Angeles 107
Jacksonville 92
Hanoi 86
Ho Chi Minh City 86
Milan 83
Buffalo 66
Lawrence 61
Lauterbourg 58
North Bergen 55
São Paulo 47
Menlo Park 45
Moscow 41
Helsinki 39
Munich 37
Orem 32
Chicago 31
London 29
Nuremberg 28
Montreal 26
Toronto 26
Brooklyn 25
Redondo Beach 24
Warsaw 24
Johannesburg 21
Phoenix 21
San Diego 21
Stockholm 20
Chennai 19
Frankfurt am Main 19
Boardman 18
Denver 18
Kraków 18
Mexico City 18
Zhengzhou 18
Shenzhen 17
Amsterdam 16
Nanjing 16
Shanghai 16
Amman 15
Jakarta 15
Norwalk 15
Seoul 15
Boston 14
Colorado Springs 14
Kunming 14
Lappeenranta 14
Manchester 14
Atlanta 13
Naples 13
Poplar 13
Bologna 12
Del Norte 12
Hefei 12
Monmouth Junction 12
Vienna 12
Columbus 11
Florence 11
Incheon 11
Rio de Janeiro 11
Creede 10
Da Nang 10
Durham 10
Guangzhou 10
Mountain View 10
Paris 10
Salt Lake City 10
Verona 10
Bari 9
Belo Horizonte 9
Newham 9
Palermo 9
Salvador 9
Brussels 8
Catania 8
Detroit 8
Guarulhos 8
Miami 8
Totale 16.604
Salva come PNG Salva come JPEG
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 625
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 510
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 489
Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia 486
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 475
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 455
Occurrence of Writing Tremor in Patients With Scans Without Evidence of Dopaminergic Deficit 449
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 442
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 440
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 439
Centrality of striatal cholinergic transmission in Basal Ganglia function 433
Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients 433
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 430
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 430
CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone--a case report 427
Double hit mouse model of Parkinson's disease 426
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. 408
Outlining a population "at risk" of Parkinson's disease: Evidence from a case-control study 402
Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia 400
Centrality of early synaptopathy in Parkinson's disease 378
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence 374
Transient parkinsonism after unilateral midbrain stroke: a compensatory intervention from the healthy side? 362
Dopaminergic involvement in a drummer with focal dystonia: A case study 325
Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus 322
Promising rodent models in Parkinson's disease 318
Assessment of serum uric acid as risk factor for tauopathies 307
Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report 307
Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease 299
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 280
Long-term treatment with rotigotine in drug-naïve PSP patients 275
Comments on: “Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review” 272
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease 268
The effect of postural deformities on back function and pain in patients with Parkinson's disease 263
Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy 255
CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients 255
Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction 253
Effectiveness of robot-assisted gait training on motor impairments in people with Parkinson's disease: A systematic review and meta-analysis 251
Dystonia as a network disorder: A concept in evolution 240
Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features 220
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease 213
Systemic activation of Nrf2 pathway in Parkinson's disease 196
Cerebrospinal fluid ferritin and siderophages in the diagnosis of superficial cerebral siderosis 193
Assessment of Psychometric Characteristics of Parkinson’s Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson’s Disease: A Validation Study 187
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human Pathology 186
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 184
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 175
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms 171
Technology-based assessment of motor impairment in de novo Parkinson's disease patients: implications for diagnostic accuracy and early identification of distinct phenotypes 160
Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease 158
Sex hormones differentially contribute to Parkinson disease in males: a multimodal biomarker study 150
The influence of postural deformities on neck function and pain in patients with Parkinson's disease 150
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia 146
Transcranial Direct Current Stimolation (tDCS) on PD Patients with Freezing of Gait: Preliminary Findings 133
Adult-onset sporadic chorea: real-world data from a single-centre retrospective study 128
Spinal vascular lesions: anatomy, imaging techniques and treatment 124
Hearing dysfunction heralds an increase in non-motor burden and a worse quality of life in Parkinson’s disease: new insights from non-motor spectrum 118
Circulating calprotectin as a potential biomarker of persistent olfactory dysfunctions in Post-COVID-19 patients 117
Cortical functional connectivity changes in the body-first and brain-first subtypes of Parkinson's disease 115
Band-Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates 113
Axial postural abnormalities and pain in Parkinson's disease 109
STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson's Disease 109
Sex hormones shape EEG-based functional connectivity in early-stage Parkinson’s disease patients 105
Physical activity changes and correlate effects in patients with Parkinson's disease during COVID-19 lockdown 105
Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy 102
Ischemic injury precipitates neuronal vulnerability in Parkinson{'}s disease: Insights from PINK1 mouse model study and clinical retrospective data 102
Insular and limbic abnormal functional connectivity in early-stage Parkinson’s disease patients with autonomic dysfunction 101
Clinical course of paroxysmal dyskinesias throughout pregnancy 101
COVID-19: dealing with a potential risk factor for chronic neurological disorders 100
Validation of the Italian version of the PSP Quality of Life questionnaire 97
Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort 97
Contribution of testosterone and estradiol in sexual dimorphism of early-onset Parkinson's disease 96
Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy 94
Early Alterations in De Novo Parkinson’s Disease Revealed by Diffusion Tensor Imaging: Preliminary Study 93
Parkinson's disease motor progression in relation to the timing of REM sleep behavior disorder presentation: an exploratory retrospective study 93
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway 90
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease 90
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 90
Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG 90
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction 89
Short‐Term Effects of Continuous Theta Burst Stimulation in Treating a Young Patient Affected by Post‐Ischemic Hemidystonia 88
Constipation distinguishes different clinical-biochemical patterns in de novo Parkinson's disease 87
Olfactory Neuron Substance P is Overexpressed in Parkinson's Disease Reflecting Gut Dysfunction 87
Motor cortex transcranial direct current stimulation improves non-motor symptoms in early-onset Parkinson’s disease: a pilot study 82
Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature 82
Gastrointestinal Dysfunction Bears on the Clinical‐Biological Profile of Parkinson's Disease 81
A biological characterization of patients with postmenopausal Parkinson's disease 80
Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study 79
Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson's Disease 79
Tau and Amyloid-beta Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters 79
Peripheral immunity changes are associated with neurodegeneration and worse clinical outcome in idiopathic normal pressure hydrocephalus 78
Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson’s disease 78
Stage-dependent phosphoproteome remodeling of Parkinson's disease blood cells 77
Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patients 77
Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort 76
Biofluids profile of ?-Klotho in patients with Parkinson{'}s disease 75
Increased blood-brain barrier permeability is associated with dysfunctional α band connectivity in early-stage Parkinson’s disease 74
Effects of head trauma and sport participation in young-onset Parkinson?s disease 73
Increase of Prokineticin-2 in Serum of Patients with Parkinson{'}s Disease 71
Using a Video Device and a Deep Learning-Based Pose Estimator to Assess Gait Impairment in Neurodegenerative Related Disorders: A Pilot Study 70
Prevenzione del rischio di disturbo muscoloscheletrico in lavoratori videoterminalisti affetti da Malattia di Parkinson. Studio ergonomico e riabilitativo 69
Totale 21.135
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.585
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/2022793 31 61 60 40 6 63 143 41 38 64 72 174
2022/2023935 98 84 29 104 74 210 131 74 75 1 37 18
2023/2024532 41 14 24 12 51 113 31 71 16 52 24 83
2024/20252.790 58 505 224 146 86 279 193 227 239 292 312 229
2025/20265.443 392 191 595 426 454 207 627 637 517 634 493 270
Totale 22.149